Alice De Bernardi - Publications

Sequencing JAK-inhibitors in ulcerative colitis: effectiveness and safety of switching within treatment class.

Journal: Journal of Crohn's & colitis

Published: November 03, 2025

Sequencing JAK-inhibitors in ulcerative colitis: effectiveness and safety of switching within treatment class.

Journal: Journal of Crohn's & colitis

Published: November 03, 2025

Multicenter Real-World Outcomes of Risankizumab in Crohn's Disease: The RESOLVE IG-IBD Study.

Journal: The American journal of gastroenterology

Published: October 27, 2025

Is it time to introduce health coaching in inflammatory bowel disease management?

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: September 29, 2025

Upper Gastrointestinal Crohn's Disease: Shedding Light on the Obscure L4 Classification Meaning.

Journal: Journal of clinical medicine

Published: September 24, 2025

Applications of generative artificial intelligence in inflammatory bowel disease: A systematic review.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: February 08, 2025

The TL1A inhibitors in IBD: what's in the pot?

Journal: Expert review of gastroenterology & hepatology

Published: January 08, 2025

Combining Advanced Targeted Therapy in Inflammatory Bowel Disease: Current Practice and Future Directions.

Journal: Journal of clinical medicine

Published: December 16, 2024

Response to Ustekinumab Therapy Is Associated with an Improvement of Nutritional Status in Patients with Crohn's Disease.

Journal: Journal of clinical medicine

Published: August 15, 2023